Air travel in patients suffering from pulmonary hypertension-A prospective, multicentre study

Athiththan Yogeswaran, Jan Grimminger, Khodr Tello, Lukas Becker, Werner Seeger, Friedrich Grimminger, Natascha Sommer, Hossein A Ghofrani, Tobias J Lange, Stefan Stadler, Karen Olsson, Jan C Kamp, Stephan Rosenkranz, Felix Gerhardt, Katrin Milger, Michaela Barnikel, Silvia Ulrich, Stéphanie Saxer, Ekkehard Grünig, Satenik HarutynovaChristian Opitz, Hans Klose, Heinrike Wilkens, Michael Halank, Melanie Heberling, Henning Gall, Manuel J Richter

Research output: Contribution to journalOriginal Articlepeer-review

Abstract

The PEGASUS study is the first multicentric and prospective assessment of the safety of air travel flying in pulmonary hypertension (PH) (NCT03051763). Data of air travel from 60 patients with PH was available. No severe adverse events occurred. Nine patients self-reported mild adverse events during flight (13%), while after landing, 12 patients reported events (20%). Solely one patient (2%) had an adverse event leading to medical consultation. In patients with PH and World Health Organization functional classes II and III, air travel was safe.

Original languageEnglish
Pages (from-to)e12397
JournalPULMONARY CIRCULATION
Volume14
Issue number3
DOIs
Publication statusPublished - Jul 2024

Fingerprint

Dive into the research topics of 'Air travel in patients suffering from pulmonary hypertension-A prospective, multicentre study'. Together they form a unique fingerprint.

Cite this